Archived story. Original version is here.
Chagas disease made the news recently when a New York Times article revealed a plan by Turing Pharmaceuticals CEO Martin Shkreli to charge from $60,000 to $100,000 for a course of benznidazole to treat Chagas disease, up from the current price of $5 to $100 for a two-month course of the drug.
Sharing